The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
Max Dahele, Suresh Senan
Cancer Res Treat. 2011;43(2):75-82.   Published online 2011 Jun 30     DOI:
Citations to this article as recorded by Crossref logo
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
Michela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, Davide Franceschini, Andrei Fodor, Isa Bossi Zanetti, Marianna Alessandra Gerardi, Paolo Borghetti, Davide Tomasini, Nadia Gisella Di Muzio, Olga Oneta, Marta Scorsetti, Ciro Franzese, P
Lung Cancer.2020; 141: 1.     CrossRef
Staging Lung Cancer
Girish S. Shroff, Chitra Viswanathan, Brett W. Carter, Marcelo F. Benveniste, Mylene T. Truong, Bradley S. Sabloff
Radiologic Clinics of North America.2018; 56(3): 411.     CrossRef
Stereotactic Body Radiation Therapy for Early-Stage Non–Small Cell Lung Cancer: A Primer for Radiologists
Jennifer A. Febbo, Ramya S. Gaddikeri, Palmi N. Shah
RadioGraphics.2018; 38(5): 1312.     CrossRef
Preliminary comparison of the registration effect of 4D-CBCT and 3D-CBCT in image-guided radiotherapy of Stage IA non–small-cell lung cancer
Zhibo Tan, Chuanyao Liu, Ying Zhou, Weixi Shen
Journal of Radiation Research.2017; 58(6): 854.     CrossRef
Narcissus, the Beam, and lung cancer
Gaetano Rocco
The Journal of Thoracic and Cardiovascular Surgery.2016; 152(2): 338.     CrossRef
Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
Taro Murai, Akihiro Hayashi, Yoshihiko Manabe, Chikao Sugie, Taiki Takaoka, Takeshi Yanagi, Tetsuya Oguri, Masayuki Matsuo, Yoshimasa Mori, Yuta Shibamoto
The British Journal of Radiology.2016; 89(1066): 20160374.     CrossRef
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Erik O. Pettersen, Peter Ebbesen, Roben G. Gieling, Kaye J. Williams, Ludwig Dubois, Philippe Lambin, Carol Ward, James Meehan, Ian H. Kunkler, Simon P. Langdon, Anne H. Ree, Kjersti Flatmark, Heidi Lyng, Maria J. Calzada, Luis del Peso, Manuel O. Landazu
Journal of Enzyme Inhibition and Medicinal Chemistry.2015; 30(5): 689.     CrossRef
Monte Carlo validation of the TrueBeam 10XFFF phase-space files for applications in lung SABR
Tony Teke, Cheryl Duzenli, Alanah Bergman, Francis Viel, Parmveer Atwal, Ermias Gete
Medical Physics.2015; 42(12): 6863.     CrossRef
Stratégies d’évaluation de la réponse après irradiation stéréotaxique des cancers bronchiques primitifs et des métastases pulmonaires
I. Barillot, O. Munier, M. Hatime, F. Mornex
Cancer/Radiothérapie.2014; 18(4): 308.     CrossRef
Short-Course Treatment With Gefitinib Enhances Curative Potential of Radiation Therapy in a Mouse Model of Human Non-Small Cell Lung Cancer
Sivan M. Bokobza, Yanyan Jiang, Anika M. Weber, Aoife M. Devery, Anderson J. Ryan
International Journal of Radiation Oncology*Biology*Physics.2014; 88(4): 947.     CrossRef
Can an alternative backround-corrected [18F] fluorodeoxyglucose (FDG) standard uptake value (SUV) be used for monitoring tumor local control following lung cancer stereotactic body radiosurgery?
Charles Shang, Michael Kasper, Vindu Kathriarachchi, Rashmi Benda, Joseph Kleinman, Jeremy Cole, Timothy Williams
International Journal of Cancer Therapy and Oncology.2014; 2(3): 020317.     CrossRef
Stereotactic ablative body radiotherapy combined with immunotherapy: Present status and future perspectives
N.H. Rekers, E.G.C. Troost, C.M.L. Zegers, W.T.V. Germeraad, L.J. Dubois, P. Lambin
Cancer/Radiothérapie.2014; 18(5-6): 391.     CrossRef
Cáncer de pulmón
P. Resano Barrio, Y. Anta Mejía
Medicine - Programa de Formación Médica Continuada Acreditado.2014; 11(67): 3983.     CrossRef
Increasing Use of Advanced Radiation Therapy Technologies in the Last 30 Days of Life Among Patients Dying As a Result of Cancer in the United States
B. Ashleigh Guadagnolo, Kai-Ping Liao, Sharon H. Giordano, Linda S. Elting, Thomas A. Buchholz, Ya-Chen Tina Shih
Journal of Oncology Practice.2014; 10(4): e269.     CrossRef
Extra-thoracic tumor burden but not thoracic tumor burden on 18F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer
Jong-Ryool Oh, Ji-Hyoung Seo, Chae Moon Hong, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee, Jung-Joon Min, Ho-Chun Song, Hee-Seung Bom, Young-Chul Kim, Byeong-Cheol Ahn
Lung Cancer.2013; 81(2): 218.     CrossRef
Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States
B. Ashleigh Guadagnolo, Jinhai Huo, Kai-Ping Liao, Thomas A. Buchholz, Prajnan Das
Cancer.2013; 119(5): 1089.     CrossRef
Escaping death to quiescence: Avoiding mitotic catastrophe after DNA damage
Zhiyuan Shen, Steven C. Huhn, Bruce G. Haffty
Cell Cycle.2013; 12(11): 1664.     CrossRef
CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer
B.A. Jereczek-Fossa, I. Bossi-Zanetti, R. Mauro, G. Beltramo, L. Fariselli, L.C. Bianchi, C. Fodor, P. Fossati, G. Baroni, R. Orecchia
Strahlentherapie und Onkologie.2013; 189(6): 448.     CrossRef
The development of stereotactic body radiotherapy (SBRT) for medically inoperable early stage non-small cell lung cancer: an international phenomenon
Gregory M. M. Videtic
Journal of Radiation Oncology.2012; 1(1): 3.     CrossRef
Improving lung cancer survival; time to move on
Marlies E Heuvers, Joost P Hegmans, Bruno H Stricker, Joachim G Aerts
BMC Pulmonary Medicine.2012;[Epub]     CrossRef
Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature
Kitty Huang, Max Dahele, Suresh Senan, Matthias Guckenberger, George B. Rodrigues, Aaron Ward, R. Gabriel Boldt, David A. Palma
Radiotherapy and Oncology.2012; 102(3): 335.     CrossRef